Skip to main content
. Author manuscript; available in PMC: 2008 Mar 5.
Published in final edited form as: Mutat Res. 2006 Dec 8;627(2):146–157. doi: 10.1016/j.mrgentox.2006.11.001

Table 1.

Information on the polymorphisms under investigation

Gene GeneID Chromosome Polymorphism Amino Acid Change Reference SNP ID Genotyping assay
GSTM1 2944 1p13.3 Deletion Multiplex PCRa
GSTT1 2952 22q11.23 Deletion Multiplex PCRa
GSTP1 2950 11q13.2 Exon 5–24 A>G Codon 105 Ile (I) → Val(V) 947894 MassCodeb
GSTP1 2950 11q13.2 Exon 6+5 C>T Codon 114 Ala (A) → Val (V) 1799811 MassCodeb
MGMT 4255 10q26 Exon 2–25 C>T Codon 84 Leu (L) → Phe (F) 12917 MassCodeb
MGMT 4255 10q26 Exon 5+13 A>G Codon 143 Ile (I) → Val (V) 2308321 PCR-SSCPa
XPD 2608 19q13.3 Exon10–16 G>A Codon 312 Asp (D) → Asn (N) 1799793 MassCodeb
XPD 2608 19q13.3 Exon23+61 A>C Codon 751 Lys (K) → Gln (Q) 13181 PCR-RFLPa
XRCC3 7517 14q32.3 Exon 8–53 C>T Codon 241 Thr (T) → Met (M) 861539 MassCodeb

From the SNP500Cancer database of the U.S. National Cancer Institute. PCR, polymerase chain reaction; SSCP, single-strand conformation polymorphism; RFLP, restriction fragment length polymorphism. GST, glutathione-S-transferase; MGMT, O6-methylguanine-DNA-methyltransferase; XPD, xeroderma pigmentosum group D; XRCC3, X-ray repair cross-complementing group 3.

a

Methods are described in reference 12 (for the GSTM1 and GSTT1 polymorphisms), reference 13 (for the MGMT I143V polymorphism) and reference 14 (for the XPD K751Q polymorphism).

b

Masscode™ technology (BioServe Biotechnologies, Ltd., Laurel, MD).